FDA issued a Warning Letter to Atlas Pharmaceuticals, LLC on 9/11/2018 as a result of this inspection.
483 Atlas Pharmaceuticals Sep 2017
483 Atlas Pharmaceuticals Sep 2017Stephanie Slater FDA$119.00 - Available Now
FDA investigators audited the Atlas Pharmaceuticals - Phoenix, AZ, United States facility and issued inspectional observations (via FDA 483) on 26 Sep 2017.
Add To Cart
- Category: Human Drugs
- Inspection end: 26 Sep 2017
- Location: Phoenix, United States
- FEI: 3013030904